Protein-Losing enteropathy after the modified fontan operation: Oral prednisone treatment with biopsy and laboratory proved improvement

1996 ◽  
Vol 17 (2) ◽  
pp. 115-117 ◽  
Author(s):  
T. M. Zellers ◽  
K. Brown
1997 ◽  
Vol 7 (3) ◽  
pp. 344-346 ◽  
Author(s):  
Gerd Stafanger ◽  
Gösta Pettersson ◽  
Joes Ramsøe Jacobsen

AbstractWe describe a patient with tricuspid atresia who, after a Fontan operation three years earlier, presented with severe protein-losing enteropathy. After conversion to a cavopulmonary connection, the symptoms regressed and substitution with albumin and immunoglobulin was no longer required.


2012 ◽  
Vol 28 (4) ◽  
pp. 224-229
Author(s):  
Kentaro Ueno ◽  
Hideaki Nakamura ◽  
Ryohei Gatayama ◽  
Sadamitsu Yanagi ◽  
Hideaki Ueda ◽  
...  

2018 ◽  
Vol 38 (6) ◽  
pp. e5-e12 ◽  
Author(s):  
Christine Peyton

Protein-losing enteropathy and plastic bronchitis remain challenging to treat despite recent treatment advances. Protein-losing enteropathy and plastic bronchitis have been diagnosed in patients with cardiomyopathy, constrictive pericarditis, and congestive heart failure. This article focuses on patients with protein-losing enteropathy or plastic bronchitis following the Fontan procedure. Patients with single-ventricle physiology who have undergone the Fontan procedure are at risk for these conditions. Fontan physiology predisposes patients to chronically low cardiac output, increased central venous pressure, and congestive heart failure. These altered hemodynamics lead to increased mesenteric vascular resistance, resulting in venous hypertension and congestion in protein-losing enteropathy. Plastic bronchitis is a complex disease in which chronic high lymphatic pressures from Fontan physiology cause acellular bronchial casts to develop. These entities may also occur in patients with normal Fontan hemodynamics. This article also covers medical and surgical interventions for protein-losing enteropathy and plastic bronchitis. (Critical Care Nurse. 2018;38[6]:e5–e12)


2001 ◽  
Vol 121 (3) ◽  
pp. 582-583 ◽  
Author(s):  
Mitchell I. Cohen ◽  
Larry A. Rhodes ◽  
Gil Wernovsky ◽  
J.William Gaynor ◽  
Thomas L. Spray ◽  
...  

2022 ◽  
Vol 18 ◽  
Author(s):  
Bart. W. Driesen ◽  
Michiel Voskuil ◽  
Heynric B. Grotenhuis

Abstract: The Fontan operation was introduced in 1968. For congenital malformations where biventricular repair is not suitable, the Fontan procedure has provided a long-term palliation strategy with improved outcome compared to the initially developed procedures. Despite these improvements, several complications merely as a result of a failing Fontan circulation (including myocardial dysfunction, arrhythmias, increased pulmonary vascular resistance, protein losing enteropathy, hepatic dysfunction, plastic bronchitis and thrombo-embolism) will limit life-expectancy in this patient cohort. This review provides an overview of the most common complications of the Fontan circulation and the currently available treatment options.


2014 ◽  
Vol 35 (7) ◽  
pp. 1225-1231 ◽  
Author(s):  
Hideto Ozawa ◽  
Takayoshi Ueno ◽  
Shigemitsu Iwai ◽  
Hiroaki Kawata ◽  
Kyouichi Nishigaki ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document